Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接秋水仙碱治疗效果不明显转而接
砜治疗的患者应当继
服用秋水仙碱。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接秋水仙碱治疗效果不明显转而接
砜治疗的患者应当继
服用秋水仙碱。
声明:以、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果明显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙效果不
显转而接受氨苯砜
患者应当继
服用秋水仙
。
:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声:以上例句、词性分
互联网资源自动生成,部分未经过人工审核,其表达内容亦
代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱果不明显转而接受氨苯砜
的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱疗效果不
显转而接受氨
疗的患者应当继
服用秋水仙碱。
声:
例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水仙碱治疗效果不明显转而接受治疗的患者应当继
服用秋水仙碱。
声明:句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,我么你建议,在开始接受秋水疗效果不明显转而接受氨苯砜
疗的患者应当继
服用秋水
。
声明:以上例句、词性分类均由互联网动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.
因此,建议,在开始接受秋水仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继
服用秋水仙碱。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人,其表达内容亦不代表本软件的观点;若发现问题,欢迎向
们指正。